Background <p>Polypharmacy can be both a public health and an economic issue. Medication reviews are structured interviews of the patient by the pharmacist, aiming at optimizing the drug treatment and deprescribing potentially inappropriate medications. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to reduce inappropriate polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed.</p> Methods <p>ABiMed associates several approaches: guidelines implementation, but also the automatic extraction of patient data from the GP’s electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops.</p> Results <p>We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested in our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge.</p> Conclusions <p>The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management

  • Abdelmalek Mouazer,
  • Romain Léguillon,
  • Nada Boudegzdame,
  • Thibaud Levrard,
  • Yoann Le Bars,
  • Christian Simon,
  • Brigitte Séroussi,
  • Julien Grosjean,
  • Romain Lelong,
  • Catherine Letord,
  • Stéfan Darmoni,
  • Matthieu Schuers,
  • Joël Belmin,
  • Karima Sedki,
  • Sophie Dubois,
  • Hector Falcoff,
  • Rosy Tsopra,
  • Jean-Baptiste Lamy

摘要

Background

Polypharmacy can be both a public health and an economic issue. Medication reviews are structured interviews of the patient by the pharmacist, aiming at optimizing the drug treatment and deprescribing potentially inappropriate medications. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to reduce inappropriate polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed.

Methods

ABiMed associates several approaches: guidelines implementation, but also the automatic extraction of patient data from the GP’s electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops.

Results

We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested in our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge.

Conclusions

The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.